Early classification schemes divided SCLC into two molecular subtypes according to the expression levels of the transcription factors achaete-scute homologue 1 (ASCL1; also known as ASH1) and neurogenic differentiation factor 1 (NeuroD1), establishing a foundational dichotomy for future research (33). Here, ASCL1 is linked to small cell lung carcinoma.